Market Tracker

10/30 7:05pm ET

Geron Corp (NASDAQ:GERN)

2.21
Data as of Oct 30
 -0.05 / -2.21%
Today’s Change
1.31
Today|||52-Week Range
7.36
-50.65%
Year-to-Date
No recent news for Geron Corp.

Today’s Trading

Previous close2.26
Today’s open2.24
Day’s range2.19 - 2.30
Volume2,592,858
Average volume (3 months)1,991,365
Market cap$354.6M
Dividend yield--
Data as of 3:59pm ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)+44.44%
Earnings growth (this year)+23.33%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.64%
P/E ratioNM
Price/Sales474.30
Price/Book4.94

Competitors

 Today’s
change
Today’s
% change
TRIBTrinity Biotech PLC+0.53+3.15%
OXFDOxford Immunotec Glo...+0.03+0.20%
TTHITransition Therapeut...-0.01-0.16%
CALACalithera Bioscience...-0.02-0.19%
Data as of 3:59pm ET, 10/30/2014

Financials

Last reporting dateOctober 31, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.3M
Annual profit (last year)-$38.4M
Net profit margin-2,991.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts